home / stock / pmcb / pmcb news

PMCB News and Press, PharmaCyte Biotech Inc. From 12/15/21

Stock Information
Company Name: PharmaCyte Biotech Inc.
Stock Symbol: PMCB
Market: OTC
Website: pharmacyte.com
Menu
PMCB PMCB Quote PMCB Short PMCB News PMCB Articles PMCB Message Board
Get PMCB Alerts

News, Short Squeeze, Breakout and More Instantly...
PMCB - PharmaCyte Biotech Reports Second Quarter 2021 Financial Results and Operational Highlights

PharmaCyte Biotech, Inc. NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today the financial results for its second quarter ended Octo...
PMCB - PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today the results of an additional, more detailed, analysis ...

PMCB - PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today the commencement of a pivotal study to determine if the tr...

PMCB - PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that the empty capsule material that makes up its CypCaps ...
PMCB - 3 Penny Stocks Waiting on FDA Approval for Rocket Fuel

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks can be dicey propositions when you’re looking to add growth to your portfolio. No one can predict the future, but it looks like we might be nearing the end of an exciting trend. As enthusiasm over biot...

PMCB - PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced further results from a third test of biocompatibility of i...

PMCB - PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today the results of a second U.S. Food and Drug Administration ...
PMCB - PharmaCyte Biotech Announces Positive Results of Biocompatibility Study for FDA

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today the first test results of the biocompatibility studies of ...

PMCB - 7 Penny Stocks Waiting on The FDA for Rocket Fuel

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Excitement over meme stocks has been effective in helping to send biotech penny stocks on wild moves higher. But as that trend continues to fade, names in this category are going to lean more on company-specific catalysts t...

PMCB - LULU, FRO and PMCB among pre market gainers

Soligenix (NASDAQ:SNGX) +26% FDA Grants soligenix orphan drug designation for the treatment of T-cell lymphoma Eloxx Pharmaceuticals (NASDAQ:ELOX) +22% announces fast track designation for ELX-02 for the treatment of cystic fibrosis patients with nonsense mutations Cardiff Oncology ...
Previous 10 Next 10